Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DanDrit Biotech USA

2001 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing gene therapies. It develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Enochian Biopharma
Former Stock Listing
ENOB
Primary Office
  • 375 Park Avenue
  • Suite 2607
  • New York, NY 10152
  • United States

DanDrit Biotech USA Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore DanDrit Biotech USA‘s full profile, request access.

Request full access to PitchBook

DanDrit Biotech USA Executive Team (1)

Name Title Board
Seat
Contact
Info
Eric Leire MD Chief Executive Officer & Director